...
首页> 外文期刊>Journal of Medicinal Chemistry >N-Hydroxybenzimidazole Inhibitors of the Transcription Factor LcrF in Yersinia: Novel Antivirulence Agents
【24h】

N-Hydroxybenzimidazole Inhibitors of the Transcription Factor LcrF in Yersinia: Novel Antivirulence Agents

机译:N-羟苯并咪唑抑制剂的耶尔森氏菌转录因子LcrF:新型抗毒剂。

获取原文
获取原文并翻译 | 示例

摘要

LcrF, a multiple adaptational response (MAR) transcription factor, regulates virulence in Yersinia pestis and Yersinia pseudotuberculosis. In a search for small molecule inhibitors of LcrF, an acrylic amide series of N-hydroxybenzimidazoles was synthesized and the SAR (structure-activity relationship) was examined, Selected test compounds demonstrated inhibitory activity in a primary cell-free LcrF-DNA binding assay as well as in a secondary whole cell assay (type III secretion system dependent Y. pseudotuberculosis cytotoxicity assay). The inhibitors exhibited no measurable antibacterial activity in vitro, confirming that they do not target bacterial growth. These results demonstrate that N-hydroxy-benzimidazole inhibitors, exemplified by 14, 22, and 36, are effective antivirulence agents and have the potential to prevent infections caused by Yersinia spp.
机译:LcrF是一种多重适应性反应(MAR)转录因子,可调节鼠疫耶尔森氏菌和假结核耶尔森氏菌中的毒力。在寻找LcrF的小分子抑制剂时,合成了N-羟基苯并咪唑的丙烯酸酰胺系列,并检测了SAR(结构-活性关系),选择的测试化合物在无细胞的原始LcrF-DNA结合试验中表现出抑制活性,如以及在第二次全细胞试验中(III型分泌系统依赖的假结核耶尔森氏菌细胞毒性试验)。抑制剂在体外没有表现出可测量的抗菌活性,从而证实它们不靶向细菌生长。这些结果证明,以14、22和36为例的N-羟基苯并咪唑抑制剂是有效的抗毒剂,并且具有预防由耶尔森氏菌引起的感染的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号